ID   1.4E7
AC   CVCL_2259
DR   CancerTools; 161632
DR   ECACC; 10070102
DR   Wikidata; Q54423238
RX   Patent=US20040005702;
RX   PubMed=21515691;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3525.
CC   Characteristics: Insulin secreting.
CC   Characteristics: Produced by electrofusion of PANC-1 with a primary culture of human pancreatic islets.
CC   Doubling time: 26 +- 1.5 hours (PubMed=21515691); ~26 hours (ECACC=10070102).
ST   Source(s): ECACC=10070102; Patent=US20040005702
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 28
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 8
ST   D8S1179: 14,15
ST   FGA: 21
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
RX   Patent=US20040005702;
RA   Flatt, Peter R.
RA   McClenaghan, Neville H.
RT   "Insulin producing cell-line.";
RL   Patent number US20040005702, 08-Jan-2004.
//
RX   PubMed=21515691; DOI=10.1074/jbc.M111.226795; PMCID=PMC3121343;
RA   McCluskey, Jane T.
RA   Hamid, Muhajir
RA   Guo-Parke, Hong
RA   McClenaghan, Neville H.
RA   Gomis, Ramon
RA   Flatt, Peter R.
RT   "Development and functional characterization of insulin-releasing
RT   human pancreatic beta cell lines produced by electrofusion.";
RL   J. Biol. Chem. 286:21982-21992(2011).
//